Topics

Dyne Appoints Brumm President & CEO, Subramanian Shifts to CSO

18:27 EDT 1 Oct 2019 | Xconomy

Joshua Brumm has been appointed president and CEO of Dyne Therapeutics. Romesh Subramanian, Dyne’s founder and former CEO, has shifted to a new role as chief scientific officer. Brumm will join Waltham, MA-based Dyne from Kaleido Biosciences (NASDAQ: KLDO), where he has been chief financial officer since last year. Kaleido said Brumm’s last day will […]

Original Article: Dyne Appoints Brumm President & CEO, Subramanian Shifts to CSO

NEXT ARTICLE

More From BioPortfolio on "Dyne Appoints Brumm President & CEO, Subramanian Shifts to CSO"

Quick Search